Literature DB >> 19217001

Illicit drug use among women with children in the United States: 2002-2003.

Leigh Ann Simmons1, Jennifer R Havens, Jason B Whiting, Jennifer L Holz, Henrietta Bada.   

Abstract

PURPOSE: Given research that shows youth exposed to maternal addiction have increased rates of cognitive, socioemotional, and behavioral problems, we examined the prevalence and correlates of past year illicit drug abuse or dependence among women with children younger than 18 years of age in the home to identify maternal risk factors.
METHODS: Data were from the 2002 and 2003 National Survey on Drug Use and Health, a nationally representative sample of the U.S. civilian population. The current analysis utilized a subsample of women (N=19,300) who reported having children younger than 18 years in the home. Past year abuse or dependence on cocaine, heroin, marijuana, stimulants, and hallucinogens as well as nonmedical use of prescription medications were assessed.
RESULTS: The prevalence of illicit drug abuse or dependence was 1.9%. Mothers reporting drug abuse or dependence had increased odds of being unmarried, controlling for other demographics. They also were more likely to report stress, poorer health status, and meet the criteria for serious mental illness (SMI).
CONCLUSIONS: Prevention and intervention strategies should focus on developing and testing methods to screen for both risk factors associated with maternal drug abuse and actual substance abuse in primary and emergency care settings to reduce youth exposure and improve child developmental outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217001      PMCID: PMC2680130          DOI: 10.1016/j.annepidem.2008.12.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  35 in total

1.  The impact of maternal alcohol and illicit drug use on children's behavior problems: evidence from the children of the national longitudinal survey of youth.

Authors:  P Chatterji; S Markowitz
Journal:  J Health Econ       Date:  2001-09       Impact factor: 3.883

2.  Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.

Authors:  James H Schluger; Gavin Bart; Mark Green; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2003-03-26       Impact factor: 7.853

3.  Screening for substance use in pregnancy: a practical approach for the primary care physician.

Authors:  I J Chasnoff; K Neuman; C Thornton; M A Callaghan
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

4.  Self-rated health. Comparisons between three different measures. Results from a population study.

Authors:  I Eriksson; A L Undén; S Elofsson
Journal:  Int J Epidemiol       Date:  2001-04       Impact factor: 7.196

5.  General and specific childhood risk factors for depression and drug disorders by early adulthood.

Authors:  H Z Reinherz; R M Giaconia; A M Hauf; M S Wasserman; A D Paradis
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-02       Impact factor: 8.829

6.  Substance use before and during pregnancy: links to intimate partner violence.

Authors:  Sandra L Martin; Jennifer L Beaumont; Lawrence L Kupper
Journal:  Am J Drug Alcohol Abuse       Date:  2003-08       Impact factor: 3.829

Review 7.  Narrative review: buprenorphine for opioid-dependent patients in office practice.

Authors:  Lynn E Sullivan; David A Fiellin
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

8.  Family pediatrics: report of the Task Force on the Family.

Authors:  Edward L Schor
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

9.  Psychopathology risk transmission in children of parents with substance use disorders.

Authors:  Duncan B Clark; Jack Cornelius; D Scott Wood; Michael Vanyukov
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

10.  Will mothers discuss parenting stress and depressive symptoms with their child's pediatrician?

Authors:  Amy M Heneghan; MaryBeth Mercer; Nancy L DeLeone
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

View more
  8 in total

1.  Cannabis Exposure in an Omani Child: First case report from Oman.

Authors:  Thuraya A Al-Shidhani; Vinita Arora
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

2.  Social support and crack/cocaine use among incarcerated mothers and nonmothers.

Authors:  Kathi L H Harp; Carrie Oser; Carl Leukefeld
Journal:  Subst Use Misuse       Date:  2012-04-02       Impact factor: 2.164

3.  Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.

Authors:  Margaret M Benningfield; Amelia M Arria; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Gabriele Fischer; Hendrée E Jones; Peter R Martin
Journal:  Am J Addict       Date:  2010 Sep-Oct

4.  Maternal patterns of marijuana use and early sexual behavior in offspring of teenage mothers.

Authors:  Natacha M De Genna; Lidush Goldschmidt; Marie D Cornelius
Journal:  Matern Child Health J       Date:  2015-03

5.  There is no age limit for methadone: a retrospective cohort study.

Authors:  Kenneth M Dürsteler-MacFarland; Marc Vogel; Gerhard A Wiesbeck; Sylvie A Petitjean
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-05-18

6.  "Moving Toward Healthy": Insights Into Food Choices of Mothers in Residential Recovery.

Authors:  Elizabeth D Wall-Bassett; Michael A Robinson; Sharon Knight
Journal:  Glob Qual Nurs Res       Date:  2016-12-02

7.  Mothers in Substance Abuse Recovery: Perspectives on Motivators, Challenges and Family Involvement.

Authors:  Natalia A Villegas; Shonaly M Chodhury; Victoria B Mitrani; Jessica Guerra
Journal:  Int J High Risk Behav Addict       Date:  2016-02-17

8.  Social Support and Resilience as Mediators Between Stress and Life Satisfaction Among People With Substance Use Disorder in China.

Authors:  Chunyu Yang; Mengfan Xia; Mengmeng Han; Ying Liang
Journal:  Front Psychiatry       Date:  2018-10-16       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.